Medication overuse headache

Current Neurology and Neuroscience Reports

Volumn 9, Issue 2, 2009, Pages 115-119

  Katsarava, Zaza ^a   Holle, Dagny ^a   Diener, Hans Christoph ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; DIHYDROERGOTAMINE; ERGOTAMINE; NEUROLEPTIC AGENT; OPIATE; OXYGEN; PLACEBO; PREDNISONE; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; SUMATRIPTAN; TOPIRAMATE; TRANQUILIZER; TRIPTAN DERIVATIVE; VALPROIC ACID; ZOLMITRIPTAN;

BEHAVIOR THERAPY; CHRONIC DAILY HEADACHE; DRUG INDUCED HEADACHE; DRUG MISUSE; DRUG WITHDRAWAL; ELECTROSTIMULATION; EPIDEMIOLOGICAL DATA; FLUID THERAPY; GENETIC POLYMORPHISM; HUMAN; MEDICAL LITERATURE; NONHUMAN; PAIN THRESHOLD; PATHOPHYSIOLOGY; PATIENT COUNSELING; PATIENT SELECTION; PROGNOSIS; PROTEIN EXPRESSION; PSYCHOLOGICAL ASPECT; PSYCHOPHYSIOLOGY; REVIEW; RISK FACTOR; SOCIAL STATUS; TREATMENT DURATION; WITHDRAWAL SYNDROME; ANIMAL; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG COMBINATION; FEMALE; HEADACHE AND FACIAL PAIN; MALE;

ANALGESICS; ANIMALS; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; FEMALE; HEADACHE DISORDERS; HUMANS; MALE; RISK FACTORS;

EID: 62649134287     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-009-0019-4     Document Type: Review

References (51)

1. Horton BT, Peters GA: Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: Report of 52 cases. Headache 1963, 3:214-226.
2. Mihatsch MJ: Das Analgetikasyndrom. New York: Thieme; 1986.
3. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988, 8(Suppl 7):1-96.
4. Kaube H, May A, Pfaffenrath V: Sumatriptan. BMJ 1994, 308:1573.
5. Limmroth V, Kazarawa Z, Fritsche G, Diener HC: Headache after frequent use of serotonin agonists zolmitriptan and naratriptan. Lancet 1999, 353:378.
6. Limmroth V, Katsarava Z, Fritsche G, et al.: Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002, 59:1011-1014.
7. International Headache Society: The International Classification of Headache Disorders. Cephalalgia 2004, 24:1-160.
8. Silberstein SD, Olesen J, Bousser MG, et al.: The International Classification of Headache Disorders, 2nd Edition (ICHD-II) - revision of criteria for 8.2 Medication-overuse headache. Cephalalgia 2005, 25:460-465.
9. Olesen J, Bousser MG, Diener HC, et al.: New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006, 26:742-746.
10. Diener HC, Dahlöf CGH: Headache associated with chronic use of substances. In The Headaches, edn 2. Edited by Olesen J, Tfelt-Hansen P, Welch KMA. Philadelphia: Lippincott Williams & Wilkins; 1999:871-878.
11. Zeeberg P, Olesen J, Jensen R: PTobable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 2006, 66:1894-1898.
12. Meskunas CA, Tepper SJ, Rapoport AM, et al.: Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache 2006, 46:766-772.
13. Zidverc-Trajkovic J, Pekmezovic T, Jovanovic Z, et al.: Medication overuse headache: Clinical features predicting treatment outcome at 1-year follow-up. Cephalalgia 2007, 27:1219-1225.
14. Castillo J, Munoz P, Guitera V, Pascual J: Epidemiology of chronic daily headache in the general population. Headache 1999, 39:190-196.
15. Colas R, Munoz P, Temprano R, et al.: Chronic daily headache with analgesic overuse: Epidemiology and impact on quality of life. Neurology 2004, 62:1338-1342.
16. Lanteri-Minet M, Auray JP, El Hasnaoui A, et al.: Prevalence and description of chronic daily headache in the general population in France. Pain 2003, 102:143-149.
17. Wang SJ, Fuh JL, Lu SR, et al.: Chronic daily headache in Chinese elderly: Prevalence, risk factors, and biannual follow-up. Neurology 2000, 54:314-319.
18. Rapoport A, Stang P, Gutterman DL, et al.: Analgesic rebound headache in clinical practice: Data from a physician survey. Headache 1996, 36:14-19.
19. Gaist D, Hallas J, Sindrup SH, Gram LF: Is overuse of sumatriptan a problem? A population-based study. Eur J Clin Pharmacol 1996, 3:161-165.
20. Evers S, Bauer B, Suhr B, et al.: The epidemiology of sumatriptan abuse. In Headache Treatment: Trial Methodology and New Drugs. Edited by Olesen J, Tfelt-Hansen P. Philadelphia: Lippincott Williams & Wilkins; 1997:149-152.
21. Srikiatkhachorn A, Anthony M: Platelet serotonin in patients with analgesic-induced headache. Cephalalgia 1996, 16:423-426.
22. Reuter U, Salomone S, Ickstein GW, Waeber C: Effects of chronic sumatriptan and zolmitriptan treatment on 5-HAT receptor expression and function in rats. Cephalalgia 2004, 24:398-407.
23. Srikiatkhachorn A, Tarasub N, Govitrapong P: Effect of chronic analgesic exposure on the central serotonin system: A possible mechanism of analgesic abuse headache. Headache 2000, 40:343-350.
24. Park JW, Kim JS, Kim YI, Lee KS: Serotonergic activity contributes to analgesic overuse in chronic tension-type headache. Headache 2005, 45:1229-1235.
25. Bendtsen L, Jensen R, Olesen J: Decreased pain detection and tolerance thresholds in chronic tension-type headache. Arch Neurol 1996, 53:373-376.
26. de Tommaso M, Libro G, Guido M, et al.: Heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in chronic tension-type headache. Pain 2003, 104:111-119.
27. Ayzenberg I, Obermann M, Nyhuis P, et al.: Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia 2006, 26:1106-1114.
28. Fumal A, Laureys S, Di Clemente L, et al.: Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 2006, 129:543-550.
29. Lance F, Parkes C, Wilkinson M: Does analgesic abuse cause headache de novo? Headache 1988, 38:61-62.
30. Bahra A, Walsh M, Menon S, Goadsby PJ: Does chronic daily headache arise de novo in association with regular analgesic use? Headache 2003, 43:179-190.
31. Zwart JA,ADyb G, Hagen K, et al.: Analgesic use: a predictor of chronic pain and medication overuse headache: The Head-HUNT Study. Neurology 2003, 61:160-164.
32. Katsarava Z, Schneeweiss S, Kurth T, et al.: Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004, 62:788-790.
33. Wiendels NJ, Knuistingh Neven A, Rosendaal FR, et al.: Chronic frequent headache in the general population: Prevalence and associated factors. Cephalalgia 2006, 26:1434-1442.
34. Kavuk I, Weimar C, Kim BT, et al.: One-year prevalence and socio-cultural aspects of chronic headache in Turkish immigrants and German natives. Cephalgia 2006, 26:1177-1181.
35. Silverman K, Evans SM, Strain EC, Griffiths RR: Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 1992, 327:1109-1114.
36. Scher AI, Stewart WF, Lipton RB: Caffeine as a risk factor for chronic daily headache: A population-based study. Neurology 2004, 63:2022-2027.
37. Zeeberg P, Olesen J, Jensen R: Efficacy of multidisciplinary treatment in a tertiary referral headache centre. Cephalalgia 2005, 25:1159-1167.
38. Zeeberg P, Olesen J, Jensen R: Discontinuation of medication overuse in headache patients: Recovery of therapeutic responsiveness. Cephalalgia 2006, 26:1192-1198.
39. Katsarava Z, Fritsche G, Muessig M, et al.: Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001, 57:1694-1698.
40. Relja G, Granato A, Bratina A, et al.: Outcome of medication overuse headache after abrupt in-patient withdrawal. Cephalalgia 2006, 26:589-595.
41. Rossi P, Di Lorenzo C, Faroni J, et al.: Advice alone vs. structured detoxification programmes for medication overuse headache: A prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 2006, 26:1097-1105.
42. Krymchantowski AV, Barbosa JS: Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 2000, 20:107-113.
43. Pageler L, Katsarava Z, Diener HC, Limmroth V: Prednisone vs. placebo in withdrawal therapy following medication overuse headache. Cephalalgia 2008, 28:152-156.
44. Boe MG, Mygland A, Salvesen R: Prednisolone does not reduce withdrawal headache: A randomized, double-blind study. Neurology 2007, 69:26-31.
45. Mathew NT, Ali S: Valproate in the treatment of persistent chronic daily headache. An open label study. Headache 1991, 31:71-74.
46. Mei D, Ferraro D, Zelano G, et al.: Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine. Clin Neuropharmacol 2006, 29:269-275.
47. Baumgartner C, Wessely P, Bingol C, et al.: Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 1989, 29:510-514.
48. Diener HC, Dichgans J, Scholz E, et al.: Analgesic-induced chronic headache: Long-term results of withdrawal therapy. J Neurol 1989,236: 9-14.
49. Schnider P, Aull S, Baumgartner C, et al.: Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: Five-year follow-up. Cephalalgia 1996, 16: 481-485; discussion 461.
50. Evers S, Suhr B, Bauer B, et al.: A retrospective long-term analysis of the epidemiology and features of drug-induced headache. J Neurol 1999, 246:802-809.
51. Katsarava Z, Muessig M, Dzagnidze A, et al.: Medication overuse headache: Rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005, 25:12-15.